APOE and Alzheimer disease: The lifetime risk for AD in people homozygous for APOE4 is extremely high (91%) relative to those with the more common APOE3 allele (20%) or the less common APOE2 allele (2.8–4.5%) (Corder et al. 1993; Corder et al. 1994).